CNR1 and depressive disorder: The clinical remission of depression has been correlated with plasma levels of eicosapentaenoyl ethanol-amide (EPEA), which is an EPA-derived eCB metabolite [1]; EPA has an affinity for CB1/2 receptors that is 100- to 1000-fold higher than those of DHA derivatives [34].